Risk Evaluation and Mitigation Strategies for US Drug Development, Second Edition

BooksBooks Member: $37.50 Nonmember: $62.50 Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesFoundationalGenericsNorth AmericaPharmaceuticalsREMSRisk managementUS Food and Drug Administration (FDA)